Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GUM HYDRAL vs Biotene for medication-induced xerostomia (MPG23b)
DRKS00009685Phase 4Completed
- Sponsor
- Uniklinik Köln - Poliklinik für Zahnerhaltung und Parodontologie
- Start
- Nov 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of GUM Hydral and sodium monofluorophosphate in xerostomia (2 arms), sponsored by Uniklinik Köln - Poliklinik für Zahnerhaltung und Parodontologie. Primary endpoint: Change in xerostomia severity (VAS score). Started Nov 2015; status: completed.
02
Drugs
GUM Hydralsodium monofluorophosphate
03
Conditions
xerostomia
Beyond the preview
Go deeper on DRKS00009685.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00009685.